Oncopeptides AB Market Cap

Oncopeptides AB has a market cap or net worth of 429.79 million as of March 9, 2026. Its market cap has increased by 42.46% in one year.

Market Cap

429.79M

Enterprise Value

496.76M

Revenue

71.12M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.58

Market Cap Chart

Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 429.79M, a decrease of -74.26%. That is a compound annual growth rate of -13.94%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	431.42M	-67.08%
Dec 30, 2025	1.31B	291.35%
Dec 30, 2024	334.83M	-53.79%
Dec 29, 2023	724.64M	-36.76%
Dec 30, 2022	1.15B	81.18%
Dec 30, 2021	632.45M	-94.51%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Corline Biomedical AB	400.85M
Ascelia Pharma AB	365.38M
FluoGuide	532.99M
Elicera Therapeutics AB	315.48M
Bio-Works Technologies AB	306.23M
Lipum AB	304.40M
Infant Bacterial Therapeutics AB	646.63M
Mendus AB	258.28M

Market Cap Rankings